Rash Relief Clear
NDC Package 15071-704-22

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Rash Relief Clear is - Change wet and soiled diapers promptly, cleanse the diaper area, and allow to dry.- Shake bottle well before use.- Spray 4-6 inches from skin.  No rub-in is required.- Apply liberally as often as necessary, with each diaper change, and especially at bedtime or anytime exposure to we diapers is prolonged. Marketed by Touchless Care Concepts Llc, this product is identified by NDC 15071-704 and is authorized under FDA application part347.

Identification & Billing

NDC Package Code
15071-704-22
Package Description
100 g in 1 BOTTLE
Product Code
15071-704
11-Digit Billing Format
15071070422
RxNorm Crosswalk
  • RxCUI: 1101332 - RASH RELIEF CLEAR 20 % / 25 % Topical Spray
  • RxCUI: 1101332 - dimethicone 200 MG/ML / petrolatum 250 MG/ML Topical Spray [Rash Relief Clear]
  • RxCUI: 1101332 - Rash Relief Clear (dimethicone 20 % / petrolatum, white 25 % ) Topical Spray
  • RxCUI: 968777 - dimethicone 20 % / petrolatum 25 % Topical Spray
  • RxCUI: 968777 - dimethicone 200 MG/ML / petrolatum 250 MG/ML Topical Spray

Clinical Specifications

Proprietary Name
Rash Relief Clear
Dosage Form
-
Usage Information
- Change wet and soiled diapers promptly, cleanse the diaper area, and allow to dry.- Shake bottle well before use.- Spray 4-6 inches from skin.  No rub-in is required.- Apply liberally as often as necessary, with each diaper change, and especially at bedtime or anytime exposure to we diapers is prolonged.

Regulatory & Marketing

Labeler Name
Touchless Care Concepts Llc
FDA Application #
part347
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
06-21-2005
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (15071-704). Click a package code to view its specific billing and regulatory data.

15071-704-11
55 g in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 15071-704-22 identifies a specific commercial package of 100 g in 1 bottle of Rash Relief Clear, labeled by Touchless Care Concepts Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Touchless Care Concepts Llc on June 21, 2005. The current certification is valid through December 31, 2017.

How is this Touchless Care Concepts Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 15071070422. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
15071-704-22
11-Digit CMS (5-4-2)
15071-0704-22

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.